JAZZ - Jazz Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
2,056,478
1,890,922
1,618,693
1,487,973
1,324,803
Cost of Revenue
118,919
121,544
110,188
105,386
102,526
Gross Profit
1,937,559
1,769,378
1,508,505
1,382,587
1,222,277
Operating Expenses
Research Development
259,001
226,616
198,442
162,297
135,253
Selling General and Administrative
684,532
683,530
544,156
502,892
449,119
Total Operating Expenses
1,171,400
1,111,644
894,663
767,183
682,534
Operating Income or Loss
766,159
657,734
613,842
615,404
539,743
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-115,246
-51,196
-94,969
-21,016
-46,893
Income Before Tax
578,992
529,463
441,117
532,446
435,933
Income Tax Expense
-33,487
80,162
-47,740
135,236
106,399
Income from Continuing Operations
608,845
447,098
487,848
396,831
329,534
Net Income
608,845
447,098
487,848
396,831
329,535
Net Income available to common shareholders
608,845
447,098
487,848
396,831
329,535
Reported EPS
Basic
-
7.45
8.13
6.56
5.38
Diluted
-
7.30
7.96
6.41
5.23
Weighted average shares outstanding
Basic
-
59,976
60,018
60,500
61,232
Diluted
-
61,221
61,317
61,870
63,036
EBITDA
-
874,465
765,907
729,184
647,799